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Regulation of the renal Na-HCO3 cotransporter: VII. Mechanism of the
cholinergic stimulation. Cholinergic agents regulate proximal tubule
acidification but the mechanism responsible for this effect is unclear. We
examined the effect of the cholinergic agent carbachol on the activity of
the Na-HCO3 cotransporter in primary cultures of the proximal tubule of
the rabbit. The activity of the cotransporter was assayed either as
HCO3-dependent 22Na uptake or as the recovery of intracellular pH in
cells perfused continuously with Cl-free physiologic solution containing
amiloride to block the Na-H antiporter. Carbachol caused a dose-
dependent stimulation of the cotransporter activity with a maximum
increase of 90% above control values at iO M and half maximal
stimulation at iO M. The stimulation was blocked by atropine and
pirenzepine indicating an effect through the Ml muscarinic receptor.
Carbachol increased intracellular calcium fourfold and the rise in cytosolic
calcium was prevented by the intracellular calcium chelator, BAPTA.
BAPTA also blocked the effect of carbachol on the cotransporter. Because
carbachol activates phospholipase C and protein kinase C, we examined
the effect of carbachol in the presence of the phospholipase C inhibitor,
U73122, or the PKC inhibitor, calphostin C, or PKC depletion. The
phospholipase C inhibitor prevented both the effect of carbachol on the
cotransporter and on the intracellular Ca. Calphostin C and PKC deple-
tion also prevented the stimulation of the cotransporter. Carbachol
increased PKC activity and caused translocation of the PKC to the
particulate fraction. We also examined the effect of the phosphatase
inhibitor, calyculin A or the calmodulin kinase inhibitor, W-13 on
carbachol stimulation. Calyculin A and W13 likewise prevented the
carbachol-induced stimulation of the cotransporter. These results demon-
strate that cholinergic stimulation modulated the activity of the cotrans-
porter through multiple pathways including phospholipase C/PKC and
phosphatase systems.
Cholinergic agents have been known for many years to alter
proximal tubule transport [1, 2], but the mechanism responsible
for this effect has remained incompletely studied. We and others
have previously shown that the cholinergic agent carbachol inhib-
its Na and H transport in the toad and turtle bladders through a
Ca-dependent mechanism [3, 4]. In addition, we have previously
shown that carbachol enhances baseline water transport in the
toad bladder while inhibiting vasopressin-stimulated water flow in
these membranes [5]. In the proximal tubule, carbachol inhibits
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HCO3 reabsorption [6] and this effect again appears to be
mediated through a Ca-dependent mechanism. In recent years,
several studies have shown that cholinergic agents may modulate
transport in other tissues, at least in part, through protein kinase
C (PKC) activation [7]. We have recently shown that the Na-
HCO1 cotransporter, the main transporter responsible for HCO3
removal out of the proximal tubule, is regulated by PKC [8]. The
present studies were therefore aimed at determining if the
cholinergic agent carbachol stimulates the basolateral Na-HCO3
cotransporter, and at defining the mechanisms responsible for this
effect.
Methods
Isolation and culture of rabbit proximal tubule cells
Primary cultures of proximal tubule were prepared as previ-
ously described [9, 10]. The cultures were maintained at 37°C in a
5% CO incubator and pH was maintained at 7.40. Media were
changed regularly every three to four days. Confluency was
reached after eight to ten days and then cells were trypsinized and
replated on clear plastic coverslips. Confluency was reached two
to three days after and the cells, which were rendered quiescent
with removal of hormones for 48 hours, were then used to
measure the Na-HCO3 cotransporter activity fluorometrically. We
have previously shown that these cultures have morphologic,
enzymatic and transport functions very similar to the original
epithelium [9, ii].
Measurement of Na-HCO3 cotransporter activity
Measurement of intracellular pH (pH1) in cultured proximal tubule
cells and fluorometric assay of Na-HCO3 cotransporter activity.
Intracellular pH was continuously measured using the pH fluo-
rescent probe, BCECF [1,2,7 biscarboxyethyl-5(6)-carboxyfluores-
cein]. The cells were bathed in a physiologic solution (see below)
containing 15 /.LM BCECF-AM at 37°C for 30 minutes. The
coverslip with cells was inserted at 45° into plastic cuvettes and
placed into a thermostatically controlled cell holder of a Perkin-
Elmer spectrofluorometer (excitation wavelength 500 or 450 nm,
emission wavelength 530 nm, slits 5 X 10 nm) and perfused at a
rate of 20 mi/mm at 37°C (see composition of the solution below).
Before each sample measurement, the spectrofluorometer was
blanked with sample of the same amount of cells not loaded with
the fluorescent dye. This was done to subtract the signal from light
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Fig. 1. A. Schematic representation of the
fluorometric assay of the Na-H antiporter. Cells
were prcpulsed with a physiologic solution
containing NI-14C1. Removal of NH4CI results in
intracellular acidification (short arrow). Upon
the addition of Na in the solution (long arrow),
pH recovers. Amiloride, I mu, prevents this pH
recovery. B. Schematic representation of a
representative Iluorometric assay of the Na-
HCO3 cotransporter. Cells grown in coverslips
and loaded with pH sensitive dye, BCECF-AM,
were perfused with a physiologic solution in
presence of 25 mu Na-HCO3. Once a steady
baseline is reached, Na is replaced by choline
resulting in intracellular acidification. With the
re-addition of Na, pH recovers. The rate of pH
recovery was used to calculate the activity of
the Na-HCO3 cotransporter.
and autofluorescence. Nigericin calibration curve was done after
each experiment to determine pH from the ratio of fluorescence
F1/F450 [12] and buffer capacity was calculated utilizing the
NH4CI loading technique [13].
For assay of the Na-HCO3 cotransporter, quiescent cells were
perfused first with Cl-free solution containing (in mM): 25
NaHCO3, 110 Na gluconate, 5 K gluconate, 9 HEPES, 2 CaSO4,
I KH2PO, 0.5 MgSO4, 10 glucose and 1 amiloride at a rate of 20
ml/min at 37°C. The extracellular pH was maintained constant at
7.40. Once a stable fluorescence signal was reached, Na was
removed by replacing Na gluconate and NaHCO3 by equimolar
amounts of choline gluconate and choline HCO3 respectively, at
pH 7.40. With removal of Na, the intracellular pH decreases and
when Na was re-added, there was rapid recovery of intracellular
pH to baseline levels (Fig. 1B). Na-HCO3 cotransporter activity
was assayed as the initial rate of pH recovery following the
addition of NaHCO4 in cells perfused with physiologic solution in
the absence of Na, and was calculated from the slope of the line
drawn tangent to the initial deflection over a period of one minute
(the time it took the solution to reach the cell was --40 seconds).
This recovery of intracellular pH observed with addition of Na
was inhibited by DIDS. In the absence of chloride and in the
presence of DIDS, this pH recovery with addition of Na was
attributed to the Na-HCO3 cotransporter [121.
Buffer capacity of the cells was determined from the intracel-
lular pH change as described [13]. In brief, cells were perfused
with HEPES-buffered Na solution containing (in mM): 138 NaC1,
4.5 KCI, 1.1 CaC12, 1.5 MgCI2 and 15 HEPES. After measuring
baseline pH1, cells were perfused with Na-free solution containing
20 NH4CI, 118 choline Cl, 4.5 KCI, 1.1 CaCl7, and 15 HEPES for
five minutes. Intracellular pH increased and reached a plateau
upon replacement of Na with NH4. Subsequent removal of NH4
caused a decrease in pH and re-addition of Na resulted in rapid
pH1 recovery. The cell buffer capacity was calculated from the
decrease in pH1 as a result of removal of NH4 using the formula
13 = [NH4]1/zpH, where [NH4]I is the intracellular concentration
of NH4 before removal of NH1/NH4 and calculated as [NH4]1 =
[NH4],,. The 10(74pH) and /pH1 are the changes in pH1 upon
removal of Ni-I4.
Measurement of Na-HCO3 cotransporter activity in primary cul-
tures of the proximal tubule cells as IiCO-dependent 22Na-uptake.
Primary cultures of rabbit proximal tubule cells grown in mono-
layers were scraped, pelleted, resuspended and incubated in a
buffer containing (in mM): 100 K gluconate, 80 sucrose, 10
HEPES, pH 7.40, 1 Mg gluconate, 2 CaSO4, 5.5 glucose and 5.0
alanine in presence of 10 M ouabain and 50 jIM ethylisopropyl
amiloride for one hour at 37°C, and then treated with vehicle or
10 M carbachol for five minutes. Reaction was started by
addition of 20 jLl of cell suspension to 90 j.d of uptake buffer
containing (in mM): 100 K gluconate, 10 HEPES, pH 7.40, 1 Mg
gluconate, 2 CaSO4, 5.5 glucose, 5 alanine, I Ci 22Na, and 40
NaHCO4 or 40 Na gluconate. The reaction was stopped after five
minutes with 3 ml ice-cold incubation solution and then poured on
a 0.45 /.Lm pore size prewetted Millipore filter. The filters were
washed three times with ice-cold incubation solution and radio-
activity measured by scintillation spectroscopy. HCO3-dependent
22Na uptake was taken as the difference in 22Na uptake in the
presence of I-1C03 and gluconate.
Measurement of intracellular Ca
Intracellular Ca ([Ca]1) was measured in cells grown on cover-
slips as described [14] with some modifications. In brief, cells were
loaded with Ca fluorescent dye, 5 !.tM Fura-2AM, in Ringer's
solution containing in mM: 141 NaCI, 4 KCI, 1 KH2PO4, 1 MgSO4,
1.7 CaCI2, 1 HEPES, and 20 glucose for one hour at 37°C. Cells
were then washed with Ringers solution and mounted in a cuvette
holder of a Perkin-Elmer spectrofluoronieter. The cells were
continuously perfused with Ringers solution containing 2 mu Ca
in the absence and in presence of io— M carbachol. Fluorescence
was measured at excitation wavelength of 340 and 380 and
emission wavelength of 510. [Ca]1 was calculated from the fluo-
rescence ratios according to the equation by Grynkiewicz, Poenie
6.2 05 10 15
Time, minutes
1 .5
1 .0
0.5
0.0
Control Carbachol
Preparation of plasma membranes from cultured proximal tubule
cells
Plasma membranes from cultured proximal tubule cells were
prepared as described [16] with some modifications. Cells were
first exposed either to vehicle or to carbachol i0- M and then
washed twice with PBS containing 1.6 m Ca gluconate. Cells
were then scraped, transferred to a pre-chilled 50 ml tube and
pelleted at 4°C at 5000 rpm for five minutes. The cell pellets were
resuspended in an ice-cold buffer containing (in mM): 60 Tris, 250
sucrose, 10 EGTA, 2 EDTA, 10 13-mercaptoethanol, 5 jig/mi
phenylmethylsulfonyl fluoride and 5 jig/mI aprotinin and soni-
cated for 45 seconds on ice. The supernatant is the cytosol
fraction. The homogenates were centrifuged at 100,000 g for one
hour at 4°C. The resulting pellets were resuspended in the above
buffer containing 0.2% Triton X-100 and centrifuged at 100,000 g
for one hour at 4°C. The supernatant was the crude membrane
fraction consisting of nuclear, plasma and mitochondrial mem-
branes.
PKC assay
PKC activity was assayed in the cytosol and particulate fractions
using the PKC assay kit from GIBCO BRL based on the
measurement of phosphorylation of acetylated myelin basic pro-
tein [17] as per the manufacturer's instruction.
Statistical analysis
Results are presented as mean SE. Statistical significance was
analyzed by the use of the paired or unpaired t-tests and analysis
of variance as appropriate.
Fig. 2. A. Diagramatic representation of the effect
of carbachol on the activity of the Na-HCO3
cotransporter measured fluorometrically. Symbols
are: (----) control; (—) carbachol; () atropine.
B. Effect of carbachol on the activity of the
cotransporter measured fluorometrically
expressed as pH unit/mm. Each bar represents
mean SEM of 7 experiments.
Fig. 3. Effect of carbachol on the Na-HCO3 cotransporter •) measured
isotopically as the difference in 22Na uptake in presence of HCO3 (LI) or
gluconate (). Each bar represents mean SEM of 7 experiments.
Materials
DMEM/F12 was purchased from Atlanta Biologicals (Norcross,
GA, USA), BCECF/AM and Fura 2-AM from Molecular Probes
(Eugene, OR, USA), [22Na] Cl from Amersham (Arlington
Heights, IL, USA), U73 122 and amiloride from Research Bio-
chemicals International (Natick, MA, USA), Calphostin C from
Calbiochem (San Diego, CA, USA), PKC assay kit and affinity
purified anti-PKC-cr isoform from GIBCO-BRL (Grand Island,
NY, USA), and Western blotting reagents and supplies from
Bio-Rad Laboratories (Hercules, CA, USA). All other chemicals
were obtained from Sigma Chemical Company (St. Louis, MO,
USA).
Results
Effect of carbachol on the Na-HCO3 cotransporter
Figure 2 shows the effect of io M carbachol on the Na-HCO3
cotransporter measured fluorometricaily. Figure 2B shows that
carbachol stimulates the activity of the Na-HCO3 cotransporter
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and Tsein (151. For calibration, the maximum and minimum ratios
from fura-2-loaded cells were taken by addition of 5 jiM ionomy-
cm and 10 msi CaC12 and by removal of Ca in the solution and
addition of 10 m EGTA, respectively.
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Carbachol, M
Fig. 4. Effect of different concentrations of carbachol on the Na-HCO3
cotransporter expressed as pH unit/mm (A) and as percent of control (B).
Each bar represents mean SEM of 5 to 8 separate experiments.
significantly from 0.84 0.06 to 1.26 0.11 pH unit/mm, P <
0.01. Figure 3 shows the effect of carbachol on the Na-HCO3
cotransporter activity measured as the difference in 22Na uptake
in presence of HCO3 or gluconate. Carbachol stimulates 22Na
uptake in presence of HCO3 but not in presence of gluconate,
thus increasing Na-HCO3 cotransporter activity from 1.31 0.16
to 2.40 0.29 nmol/mg protein/5 mm, P < 0.01. Figure 4 shows
the effect of different concentrations of carbachol on Na-HCO3
cotransporter activity measured fluorometrically, expressed as pH
unit/mm and % of control. Carbachol elicited a concentration-
dependent increase in Na-HCO3 cotransporter activity with a
maximum increase of 90% above control values at i0 M and an
apparent half-maximum stimulation at iO M. Carbachol did not
affect baseline intracellular pH (7.31 0.12 vs. 7.26 0.06 pH
unit) or buffer capacity (21.50 5.01 vs. 23.72 3.86 mM/pH
unit). To determine whether the effect of carbachol to stimulate
the Na-HCO3 cotransporter activity is mediated through a mus-
Fig. 5. Effect of atropine (A) and pirenzepine (B) on carbachol stimulation
of the Na-HCO3 cotransporter. Cells were incubated either with vehicle
alone or with iO- M atropine () or i0 M pirenzepine () for five
minutes and then perfused with physiologic solution in the absence () or
in the presence of iO M carbachol (•, Li or ). Each bar represents
mean SEM of 5 to 6 experiments.
carinic receptor, we performed experiments in the presence of
atropine, iO M or the specific Ml antagonist, pirenzepine, iO
M. Figure 5 shows that the effect of carbachol to stimulate the
Na-HCO3 cotransporter was totally prevented by atropine and
pirenzepine.
P< 0.001P< 0.01P<0.05 ILP<0.02
P<0.05
10 106 10-s
Carbachol, M
A
B
0
C00
0
Control 10-8
2.0
1.5
1.0
0.5
0.0
250
200
150
100
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0
1 0-
P< 0.01
< 0.001
Control 10-8 10 10-6 1O iO
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Ca. Addition of i0 M carbachol caused a rapid increase in [Ca]1
that returned to normal within five minutes. In six different
experiments, carbachol caused a significant increase in [Ca]1 from
209.2 35.09 to 1825.7 421.6 nivi, P < 0.01. The fact that the
effect of carbachol to increase intracellular calcium was blocked
by atropine and by the intracellular Ca chelator, BAPTA (Fig.
6A), suggests that the increase in [Ca]1 originated mainly from
release of intracellular organdies. The effect of carbachol was still
present when the cells were perfused with physiologic solution
containing no calcium (data not shown). To examine the func-
tional role of the rise in [Ca]1 in mediating the effect of carbachol
on the Na-HCO3 cotransporter, we performed experiments in
cells loaded with the intracellular Ca chelator, BAPTA (5 jiM), for
two hours. Figure 6B shows that in control cells, carbachol caused
a significant increase in Na-HCO3 cotransporter activity and this
effect is totally prevented by BAPTA, (in pH unit/mm: control,
1.36 0.06; carbachol, 1.90 0.13; BAPTA 1.40 0.02;
carbachol + BAPTA, 1.46 0.06; P < 0.001 for control vs.
carbachol, P < 0.01 for carbachol vs. carbachol + BAPTA). Thus,
BAPTA inhibits both the effect of carbachol to increase [Ca]1 and
the effect on the cotransporter activity, suggesting that the rise in
[Ca]1 is important in mediating the effect of carbachol on trans-
Effect of carbachol on phospholipase C/protein kinase C system
2
1.5
0.5
0
Fig. 6. A. Effect of carbachol on intracellular calcium. Schematic diagram
showing cells loaded with Fura-2AM and continuously perfused with a
physiologic solution containing 2 m Ca (control;----) and either carbachol
10 M alone (—), or carbachol + atropine iO M or BAPTA 5 jiai
(°°). B. Effect of BAPTA on the activity of the Na-HCO3 cotransporter.
Cells were incubated with vehicle or BAPTA () for two hours at 37°C
and then perfused with physiologic solution in the absence (L) or in the
presence of carbachol (•, 2). Each bar represents mean 5EM of 5 to 6
experiments. *p < 0.001, control versus carbachol; **p < 0.01, carbachol
versus carbachol + BAPTA.
Effect of carbachol on [Ca]1
The effect of carbachol on [Ca] was measured in primary
cultures of the proximal tubule, loaded with Fura-2AM and
continuously perfused with a physiologic solution containing 2 mrvi
Because carbachol has been suggested to activate the phospho-
lipase C/PKC system in other tissues [TI, we examined the role of
this pathway in modulating the effect of carbachol on the activity
of the cotransporter. The phospholipase C inhibitor, U73 122, was
used to determine whether the effect of carbachol could be
mediated through this pathway. Figure 7A shows that the inhib-
itor alone did not alter the baseline activity of the cotransporter,
but significantly prevented the effect of carbachol to increase
cotransporter activity. The inhibitor also prevented the effect of
carbachol to increase intracellular Ca (Fig. 7B).
Because phospholipase C activation raises PKC activity, we
examined the effect of carbachol on PKC activity, distribution of
PKC a isoform in cytosol and particulate fractions and the effect
of PKC inhibitor or PKC depletion on the Na-HCO3 cotrans-
porter activity. Figure 8A shows that the effect of carbachol to
stimulate the Na-HCO3 cotransporter activity was completely
prevented by the specific PKC inhibitor, calphostin C (in pH
unit/mm: carbachol 1.98 0.19; carbachol 2.64 0.09; calphostin
C, 1.81 0.14; carbachol + caiphostin C, 1.53 0,11;P <0.01 for
control vs. carbachol, P < 0.001 for carbachol vs. carbachol +
caiphostin C). Figure 8B shows the effect of carbachol in the
presence of PKC depletion (in pH unit/mm: control, 1.84 0.18;
carbachol, 2.64 0.09; carbachol + PKC depletion 1.88 0.26;
P < 0.05 for control vs. carhachol and carbachol vs. carbachol +
PKC depletion). PKC depletion was accomplished by incubation
of the cells with 106 M PMA, for 72 hours. We have previously
shown that this protocol results in approximately 80% depletion
of PKC activity in cytosol and particulate fraction without affect-
ing cell viability and the activity of the cotransporter [181. It can be
seen in Figure 8B that in presence of PKC depletion, the effect of
carbachol to stimulate the cotransporter was completely pre-
vented. Table I shows that carbachol stimulated total PKC
activity, with a significant increase in the particulate fraction and
a concomitant decrease in the cytosolic fraction suggesting trans-
location of PKC.
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Effec1 of U73122 on stimulation of Na-HCO, cotransponer hr
:elts were incubated with vehicle or IOMM U73 122 (Q) for five
vr nd then nerfused with nhvsinkrnic saliitinn in the absence 0.0
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Fig. 7. .4. Effect of U73 12  on stimulation of Na-  cotransporter by
carbachol. C ll   i t  it  e icle or 10 .rM U731 2 () f fi
minutes at 37°C and the  perfused with physiologic solution in the a e
(fl) or in the presence of carbachol (U, C). Each bar represents mean
SEM of 5 experiments. B. Effect of U73 122 on intracellular Ca in cells
pretreated with vehicle (El, U) or 10 rM U73 122 (C) and then perfused
with carbachol (U, El). Each bar represents mean SEM of 4 to 7
experiments.
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Fig. 8. 4 Effect of caiphostin C on stimulation of Na-HCO cotransporter
by carbachol. Cells were incubated with vehicle or 50 nM calphostin C ()
overnight and then perfused with physiologic solution in the absence (fl)
or in the presence of carbachol (U, El). Each bar represents mean SEM
of 5 to 8 experiments. °P < 0.01, control versus carbachol; **p < 0.001,
carbachol versus carbachol + calphostin C. B. Effect of PKC depletion on
the stimulation of Na-HCO1 cotransporter by carbachol. Cells were
treated either with DMSO (El, I) or with 10—6 M PMA (, ) for 72 hours
at 37°C and then perfused with physiologic solution in absence (El) or in
presence of l0 M carbachol (U, ). Each bar represents mean SEM of
7 to 8 experiments. °P < 0.001, control versus carbachol; **p < 0.02,
carbachol versus carbachol + PMA 72 hours.
Effect of carbachol on protein phosphatases
To examine the possible role of phosphorylation of the cotrans-
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To determine if carbachol has additional effect on the cotrans-
porter beyond attributable to PKC stimulation, we examined the
effect of this agent on the cells in which the cotransporter had
been stimulated by PMA for five minutes. As can be seen in
Figure 10, the effect of PMA and carbachol were additive
suggesting an additional effect of carbachol besides PKC stimu-
lation. porter by carbachol, we performed experiments using calyculin A,
r (vtosol Particulate Total activity
**
Control L)457 287.9 738,3 t 178.7 1674.0 -t 461.3
Carhachol 470.4 150.8 1556.4 t 215.8 2026.8 132.9
arbaehoI +
calphostin (7
617.2 191.4 678.0 174.6 1295.2 t 315.0
Each data point represents mean St 1 of S to 6 experiments.
a P < 0.02, control particulate vs. carbachol particulate
P.c 0.023.0
2.5 1-
Pc 0.01
**
2.0 I-
1.5
1.0
0.5 k
0.0
Control Carbachol PMA 5' +
Carbachol
FIg. 20. Effect of I'.%i.I on curba rho! stimulation if the Nu-I!( '0, corrans-
porter. Cells were pretreated with vehicle (0. U) or PMA (.) tbr five
minutes and then perfused with carbachol I.. f2J. Each bar represent
mean SEM of 6 to 7 experiments.
1.97 0.14 calyculin A, 1.44 0.06: carhachol + calyculin A,
1.63 0.12 pH units/mm). Likewise, W- 13 (Fig. 9) also prevented
the stimulatoiy effect of carbachol on the cotransporter (control.
1.48 0.04; carbachol, 2.36 0.16; W-13, 1.47 t 0.U5; carbachol
÷ W-13, 1.56 0.08).
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Fig. 10. Effect of PMA ar chol stimulation of t  Na-HCO? Cot rans-
ls ere pretreate  ith vehicle (,  r P A () for five
inutes and then perfused with carbachol (U, ). Each bar represent
 f 6 to 7 e periments.
0.5
0.0
Fig. 9. A. Effect of calyculin A on carbachol stimulation of the Na-HCO3
cotransporter. Cells were incubated with vehicle (, •) or calyculin A 2 n
(, 1) and then perfused with carbachol (U, C). Each bar represents
mean SEM of 6 experiments. *f < 0.01, control versus carbachol; **p <
0.05, carbachol versus carbachol + calyculin. B. Effect of W-13 on
carbachol stimulation of the Na-HCO3 cotransporter. Cells were pre-
treated with vehicle (E, U) or W-13, 100 .rM (, ) and then perfused
with carbachol (U, ). Each bar represents mean SEM of 4 to 8
experiments. *R < 0.001, control versus carbachol; **p < carbachol
versus carbachol + W-13.
a specific serine/threonine phosphatase inhibitor and W-13, an
inhibitor of calmodulin kinase 11. Figure 9 shows that calyculin A,
2 flM, significantly prevented the stimulation of the Na-HCO3
cotransporter induced by carbachol without affecting the baseline
activity of the cotransporter (control, 1.52 0.14; carbachol,
. . ; calyculin A, 1. 4 . ; carbac l  cal c li  ,
. .   its/ ). Likewise, W-13 (Fig. 9) also prevented
t ry e fect of carbachol on the cotrans rter (c trol,
. . ; r l, 2.36 , ; - , . 0.05; carbac l
+ -13, 1.56 . ).
Discussion
The present study was aimed at defining the mechanism
responsible for the enhancement of proximal acidification by
carbachol. Although this agent has been shown by micropuncture
studies to enhance acidification [61, the mechanism responsible
for this effect has remained unclear. Studies in analogs of mam-
malian distal nephron and in the isolated cortical collecting tubule
of the rabbit have shown that carbachol alters Nat, water and H
transport, at least in part, through a calcium/PKC-dependent
mechanism [5]. In the present study, we studied the effect of
carbachol in primary cultures of the proximal tubule that have
been extensively characterized in our laboratory and have been
shown to contain a Na-HCO3 cotransporter that can be modu-
lated by glucocorticoid, protein kinase C, angiotensin II and PTH
[11, 19—21]. We therefore utilized this system to characterize the
A Table 1. PKC activity (pmol/mg prot/min)
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effect and the mechanism of the cholinergic agent carbachol on
Na-HCO3 cotransporter activity. Carbachol stimulated the Na-
HCO3 activity measured either by changes in pH or isotopically
as HCO3-dependent 22Na uptake. In a previous study, we docu-
mented in detail that these cells display Na-HCO3 cotransporter
activity when assayed by either technique and that both tech-
niques gave similar and consistent results [11]. The fluorometric
technique is faster, cheaper, safer and can be repeated in the same
slide. Our results clearly show that carbachol stimulates Na-HCO3
cotransporter activity through a muscarinic (Ml) receptor with
half-maximum stimulation at i0 M, suggesting that this system
regulates the activity of the cotransporter physiologically.
To examine the mechanism whereby the cholinergic system
regulates the activity of the cotransporter, we examined the effect
of this agent on [Ca]1, and the phospholipase /PKC system.
Carbachol clearly caused a four- to fivefold rise in [Ca],, and this
effect was blocked by the intracellular Ca chelator, BAPTA. The
rise in [Ca]1 is important in mediating the effect of carbachol on
the cotransporter is supported by the finding that the intracellular
calcium chelator, BAPTA, blocked both the [Ca]1 rise as well as
the effect on the cotransporter. These results suggest that the rise
in [Ca] by carbachol is, at least in part, causally related to the
stimulation of the cotransporter. Although not studied in detail, it
appears that the rise in [Ca]1 by carbachol is mainly derived from
intracellular stores, as suggested by the rapid rise in [Ca]1 and also
by the fact that when the cells were perfused with nominally
Ca-free solution, the rise in [Ca]1 was still observed.
To define the mechanism responsible for the rise in [Ca],, we
examined the effect of phospholipase C system. Since carbachol
has been shown to activate this system in other cells [22] this
activation could account for the rise in cytosolic Ca. The role of
phospholipase C was examined using the inhibitor, U73 122, which
is relatively specific for this pathway [22]. We have shown
previously that this inhibitor prevented arachidonic acid release
by angiotensin II/PTH in primary cultures of the proximal tubule
on the basolateral membranes, respectively [19,20]. This inhibitor
both prevented the effect of carbachol on the Na-HCO3 cotrans-
porter and on the intracellular Ca.
We also examined the potential role of the PKC system in
mediating the effect of carbachol on the cotransporter. We have
previously shown that PKC activity enhances the activity of the
Na-HCO3 cotransporter in basolateral membranes and in primary
cultures of the proximal tubule by two distinct mechanisms [21].
An early effect (observed in 5 mm) is mediated through phos-
phorylation of the cotransporter and a late effect (2 hr) that
appears to be mediated by enhanced synthesis of cotransporters.
The effect of carbachol to stimulate the cotransporter activity was
clearly prevented by the PKC inhibitor, caiphostin C, an inhibitor
we have previously shown not to alter the baseline activity of the
cotransporter. At the concentration used, calphostin C is specific
for PKC and does not appear to alter other kinases [23]. Further
evidence for a role of PKC in mediating the effect of carbachol is
supported by the findings that PKC depletion also prevented the
effect of carbachol. We have previously shown that the protocol
used to induce PKC depletion caused an 80% loss of PKC activity
in membrane and cytosol without affecting cell viability [18]. The
above results suggest that PKC plays a critical role in mediating
the stimulation of the cotransporter by carbachol, and is in
agreement with previous studies showing that PKC stimulates
cotransporter activity [8]. The present studies provide direct
evidence that carbachol increases total PKC activity and particu-
late fraction PKC activity with translocation of PKC a isoform,
the main isoform present in the proximal tubule.
The finding that in the presence of PMA stimulation, carbachol
was able to further enhance the activity of the cotransporter
suggests an additional mechanism for the stimulatory effect of
carbachol. This additional mechanism could be through phos-
phorylation of the cotransporter because phosphatase inhibitor
and calcium calmodulin kinase inhibitor prevented the effect of
carbachol.
Taken together, our results demonstrate that carbachol in-
creases the activity of the Na-HCO3 cotransporter through mul-
tiple pathways with the phospholipase CIPKC system playing a
major role in mediating this effect. Our studies do not exclude the
possibility that other pathways, including tyrosine kinase or phos-
pholipase D, may play a role in the cholinergic modulation of the
cotransporter.
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